MedTrace Logo

The ASSURE ROT Registry: Bioresorbable Vascular Scaffold Following Rotablation for Complex Coronary Lesions

NCT01915420 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2015-02-06

No results posted yet for this study

Summary

The registry aims to evaluate the safety, performance and efficacy of the Everolimus-eluting bioresorbable vascular scaffold (BVS) system following rotational atherectomy in patients with complex de novo native coronary artery lesions in all-day clinical practice.

Conditions

Sponsors & Collaborators

  • Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.

    lead OTHER

Principal Investigators

  • Detlef G Mathey, Prof. Dr. · Medical Care Center Prof. Mathey, Prof. Schofer GmbH

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-08-31
Completion
2017-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01915420 on ClinicalTrials.gov